LeAnne M. Zumwalt's most recent trade in Akebia Therapeutics Inc. was a trade of 53,600 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 53,600 | 53,600 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 35,700 | 109,400 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,000 | 73,700 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 43,700 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 13,700 (0%) | 0% | 0 | Common Stock |